Calaris Diagnostics Selected for Two National Health Innovation Accelerators
Calaris Diagnostics, Inc., a medical diagnostics company developing saliva-based point-of-care tests for the early detection of fatty liver disease and head & neck cancer, today announced its selection into two health innovation accelerator programs.
